
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532E428AF21CA3052E4200384DCBC8.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="plosone">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="PLOS One">
<meta name="citation_title" content="Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T">
<meta name="citation_author" content="Christian Salbach">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Mustafa Yildirim">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Barbara Ruth Milles">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Hauke Hund">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Matthias Mueller-Hennessen">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Norbert Frey">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Hugo Katus">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_author" content="Evangelos Giannitsis">
<meta name="citation_author_institution" content="Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="20">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e0330164">
<meta name="citation_doi" content="10.1371/journal.pone.0330164">
<meta name="citation_pmid" content="40839563">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/pdf/pone.0330164.pdf">
<meta name="description" content="Guidelines of the European Society of Cardiology recommend a clinical risk assessment for patients with atrial fibrillation (AF). However, scores such as the CHA2DS2-VASc score show only a modest performance for prediction of adverse endpoints. This ...">
<meta name="og:title" content="Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA2DS2-VASc score utilizing highly sensitive cardiac troponin T">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Guidelines of the European Society of Cardiology recommend a clinical risk assessment for patients with atrial fibrillation (AF). However, scores such as the CHA2DS2-VASc score show only a modest performance for prediction of adverse endpoints. This ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12370022">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1371/journal.pone.0330164"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/pone.0330164.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370022%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12370022/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12370022/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-plosone.png" alt="PLOS One logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to PLOS One" title="Link to PLOS One" shape="default" href="https://doi.org/10.1371/journal.pone.0330164" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">PLoS One</button></div>. 2025 Aug 21;20(8):e0330164. doi: <a href="https://doi.org/10.1371/journal.pone.0330164" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1371/journal.pone.0330164</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22PLoS%20One%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22PLoS%20One%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22PLoS%20One%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Improvement in risk prediction for patients with atrial fibrillation and intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc score utilizing highly sensitive cardiac troponin T</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salbach%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Christian Salbach</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Christian Salbach</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Salbach%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christian Salbach</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yildirim%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mustafa Yildirim</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mustafa Yildirim</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yildirim%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mustafa Yildirim</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Milles%20BR%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Barbara Ruth Milles</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Barbara Ruth Milles</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Milles%20BR%22%5BAuthor%5D" class="usa-link"><span class="name western">Barbara Ruth Milles</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hund%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Hauke Hund</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Hauke Hund</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hund%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hauke Hund</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mueller-Hennessen%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Matthias Mueller-Hennessen</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Matthias Mueller-Hennessen</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Data curation</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mueller-Hennessen%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Matthias Mueller-Hennessen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frey%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Norbert Frey</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Norbert Frey</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Resources, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Frey%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Norbert Frey</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katus%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Hugo Katus</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Hugo Katus</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Project administration, Resources, Supervision</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Katus%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hugo Katus</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giannitsis%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Evangelos Giannitsis</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Evangelos Giannitsis</span></h3>
<div class="p">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div>Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Writing – original draft, Writing – review &amp; editing</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Giannitsis%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Evangelos Giannitsis</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Seunghwa Lee</span><sup>2</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff001">
<sup>1</sup>Department of Internal Medicine III, Cardiology, University Hospital of Heidelberg, Heidelberg, Germany</div>
<div id="edit1">
<sup>2</sup>Wiltse Memorial Hospital, KOREA, REPUBLIC OF</div>
<div class="author-notes p">
<div class="fn" id="cor001">
<sup>✉</sup><p class="display-inline">* E-mail: <span>evangelos.giannitsis@med.uni-heidelberg.de</span></p>
</div>
<div class="fn" id="coi001"><p><strong>Competing Interests: </strong>MMH received research funding from BRAHMS, Thermo Fisher Scientific and Roche Diagnostics. EG received honoraria for lectures from Roche Diagnostics, AstraZeneca, Bayer, Daiichi-Sankyo, Lilly Eli Deutschland. He serves as a consultant for Roche Diagnostics, BRAHMS, Thermo Fisher Scientific, Boehringer Ingelheim and has received research funding from BRAHMS, Thermo Fisher Scientific, Roche Diagnostics, Bayer Vital and Daiichi Sankyo. NF has received speaker honoraria from Daiichi Sankyo, Astra Zeneca, Boehringer Ingelheim and Bayer Vital. He serves as a consultant for CMS. BRM, received research funding from Daiichi Sankyo. There are no disclosures for MY, HH, HK and CS. This does not alter our adherence to PLOS ONE policies on sharing data and materials.</p></div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Christian Salbach</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Mustafa Yildirim</span></strong>: <span class="role">Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Validation, Visualization, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div>
<strong class="contrib"><span class="name western">Barbara Ruth Milles</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hauke Hund</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Matthias Mueller-Hennessen</span></strong>: <span class="role">Data curation</span>
</div>
<div>
<strong class="contrib"><span class="name western">Norbert Frey</span></strong>: <span class="role">Resources, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Hugo Katus</span></strong>: <span class="role">Project administration, Resources, Supervision</span>
</div>
<div>
<strong class="contrib"><span class="name western">Evangelos Giannitsis</span></strong>: <span class="role">Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Writing – original draft, Writing – review &amp; editing</span>
</div>
<div class="p">
<strong class="contrib"><span class="name western">Seunghwa Lee</span></strong>: <span class="role">Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 19; Accepted 2025 Jul 28; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 Salbach et al</div>
<p>This is an open access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12370022  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40839563/" class="usa-link">40839563</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec001"><h3 class="pmc_sec_title">Background</h3>
<p>Guidelines of the European Society of Cardiology recommend a clinical risk assessment for patients with atrial fibrillation (AF). However, scores such as the CHA<sub>2</sub>DS<sub>2</sub>-VASc score show only a modest performance for prediction of adverse endpoints.</p></section><section id="sec002"><h3 class="pmc_sec_title">Methods</h3>
<p>This retrospective single-center all-comer study uses data from the Heidelberg Registry of Atrial Fibrillation of 9,995 patients with non-valvular AF presenting to the emergency department (ED) of the University Hospital of Heidelberg from June 2009 until March 2020. Per CHA<sub>2</sub>DS<sub>2</sub>-VASc, risk was classified as low (0 point in men, ≤ 1 point in females), intermediate, or high (≥2 points in men and ≥3 points in females). The predictive performance of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score, with and without highly sensitive cardiac troponin T (hs-cTnT), was evaluated for a composite endpoint comprising stroke, myocardial infarction (MI) or all-cause mortality.</p></section><section id="sec003"><h3 class="pmc_sec_title">Results</h3>
<p>Performance of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score for the prediction of the composite endpoint was poor Area under the curve (AUC): 0.648 (95%CI: 0.638–0.657) particularly in patients at intermediate-risk AUC: 0.542 (95%CI: 0.508–0.575). Adding hs-cTnT improved discrimination substantially in intermediate-risk patients (AUC: 0.778, 95% CI: 0.748–0.805). Notably, no events occurred in intermediate-risk patients with undetectable hs-cTnT (&lt;5 ng/L).</p></section><section id="sec004"><h3 class="pmc_sec_title">Conclusion</h3>
<p>In patients with AF at intermediate thromboembolic risk, the addition of hs-cTnT to the CHA₂DS₂-VASc score enhances prediction of adverse cardiovascular outcomes. Hs-cTnT may help identify patients who could benefit from anticoagulation, while also identifying a low-risk subgroup unlikely to experience events.</p></section></section><section id="sec005"><h2 class="pmc_sec_title">Introduction</h2>
<p>Patients with atrial fibrillation (AF) have a manifold higher risk of stroke and suffer from a substantial burden of the disease [<a href="#pone.0330164.ref001" class="usa-link" aria-describedby="pone.0330164.ref001">1</a>–<a href="#pone.0330164.ref003" class="usa-link" aria-describedby="pone.0330164.ref003">3</a>]. Recent improvements for stroke prevention in AF patients include the replacement of vitamin-K-antagonist (VKA) by direct oral anticoagulant (DOAC) agents such as thrombin or factor Xa-inhibitors [<a href="#pone.0330164.ref004" class="usa-link" aria-describedby="pone.0330164.ref004">4</a>]. In clinical reality, AF is the most frequent arrhythmia in the setting of an emergency department (ED), causing rising costs and health care burden [<a href="#pone.0330164.ref005" class="usa-link" aria-describedby="pone.0330164.ref005">5</a>,<a href="#pone.0330164.ref006" class="usa-link" aria-describedby="pone.0330164.ref006">6</a>]. For the reduction of stroke risk in AF patients, initiation of adequate anticoagulation has been shown to be valuable but must be carefully balanced against the risk of higher bleeding rates [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>,<a href="#pone.0330164.ref008" class="usa-link" aria-describedby="pone.0330164.ref008">8</a>]. Thus, guidelines of the European Society of Cardiology (ESC) recommend a clinical risk-factor based scoring system for the prediction of a patient individual stroke and bleeding risk [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>]. Herein, several scores exists including the CHA<sub>2</sub>DS<sub>2</sub>-, CHA<sub>2</sub>DS<sub>2</sub>-VA- and the CHA<sub>2</sub>DS<sub>2</sub>-VASc score for evaluating stroke risk and guide decision of oral anticoagulation. [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>] Unfortunately the ability of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score to predict stroke is modest which has prompted the introduction of other validated scores such as the ABC (age, biomarkers, clinical history) stroke risk score, ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) score, ORBIT (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) score, and the GARFIELD-AF (Global Anticoagulant Registry in the FIELD – Atrial Fibrillation) tool [<a href="#pone.0330164.ref009" class="usa-link" aria-describedby="pone.0330164.ref009">9</a>–<a href="#pone.0330164.ref012" class="usa-link" aria-describedby="pone.0330164.ref012">12</a>]. Current guideline recommendations regarding initiation of oral anticoagulation are clear for patients at high and low risk, whereas decision-making and risk prediction remains uncertain for those at intermediate risk according to CHA₂DS₂-VASc or CHA₂DS₂-VA score. [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>,<a href="#pone.0330164.ref013" class="usa-link" aria-describedby="pone.0330164.ref013">13</a>] No specific guideline recommendations definitively guides management in this subgroup, making individualized assessment particularly important. Given this clinical uncertainty, we focused on patients at intermediate risk according to CHA₂DS₂-VASc score to evaluate whether biomarker-based risk stratification could provide more precise risk stratification for adverse outcomes. Several studies have been prompted to improve risk prediction of risk-factor based scores by using biomarkers [<a href="#pone.0330164.ref014" class="usa-link" aria-describedby="pone.0330164.ref014">14</a>–<a href="#pone.0330164.ref018" class="usa-link" aria-describedby="pone.0330164.ref018">18</a>]. For Asian patients with clinically low-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc score and non-valvular AF, current evidence suggests that biomarkers such as NT-proBNP and creatinine could refine stroke risk stratification and prediction of adverse outcomes [<a href="#pone.0330164.ref019" class="usa-link" aria-describedby="pone.0330164.ref019">19</a>]. Thus, the current study aimed to evaluate an improvement in risk prediction of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score by using highly sensitive cardiac troponin T (hs-cTnT) and retrospective data from the Heidelberg Registry of Atrial Fibrillation (HERA-FIB).</p></section><section id="sec006"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec007"><h3 class="pmc_sec_title">Study population, design and follow-up</h3>
<p>HERA-FIB consecutively included AF patients presenting between June 2009 and March 2020 to the ED of University Hospital of Heidelberg. Design and rationale of HERA-FIB, such as inclusion and exclusion criteria were published earlier [<a href="#pone.0330164.ref020" class="usa-link" aria-describedby="pone.0330164.ref020">20</a>]. Inclusion criteria were comprehensive including age ≥ 18 years and AF either as primary reason for admission to the ED or as a comorbidity. Patients were excluded from the study for nonavailability of at least one hs-cTnT value or when lost to follow-up for all-cause mortality. For the current study, patients with valvular AF, defined as patients with mechanical prosthetic heart valve(s) or moderate/severe mitral stenosis were excluded [<a href="#pone.0330164.ref021" class="usa-link" aria-describedby="pone.0330164.ref021">21</a>]. A flow diagram for in- and excluded patients within this study is shown in <strong><a href="#pone.0330164.g001" class="usa-link">Fig 1</a></strong>. For outcome parameters, a sequential follow-up method was performed as previously described including screening of electronical patient data, phone calls and postal questionnaires and at least a contact to registrational offices for vital status [<a href="#pone.0330164.ref020" class="usa-link" aria-describedby="pone.0330164.ref020">20</a>]. This study was conducted according to ethical principles stated in the Declaration of Helsinki (2008) and was reviewed and approved by the local ethics committee of the Medical Faculty of Heidelberg. Data was accessed for research purposes 1<sup>st</sup> April 2024. No written informed consent was required. Patient identifiable data was pseudonymized to ensure data confidentiality and was not passed on to third parties. HERA-FIB is registered at ClinicalTrials.gov. Clinical Trials.gov identifier: <a href="https://clinicaltrials.gov/ct2/show/NCT05995561" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05995561</a>.</p>
<figure class="fig xbox font-sm" id="pone.0330164.g001"><h4 class="obj_head">Fig 1. Flow-diagram for included AF patients admitted to the ED. The diagram shows patient recruitment after in- and exclusion of AF patients.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370022_pone.0330164.g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce36/12370022/bd71b2ef14fd/pone.0330164.g001.jpg" loading="lazy" height="484" width="704" alt="Fig 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330164.g001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Abbreviations: AF, atrial fibrillation; ED, emergency departement; hs-cTnT, highly sensitive cardiac troponin T.</p></figcaption></figure></section><section id="sec008"><h3 class="pmc_sec_title">Definitions</h3>
<p>For this study, a composite endpoint including stroke, myocardial infarction (MI) or all-cause mortality was chosen. Stroke events included ischemic or unknown cause of stroke but excluded hemorrhagic strokes, which were allocated as a major bleeding event according to International Society on Thrombosis and Hemostasis (ISTH) major bleeding criteria. The outcome of major bleeding events was defined according to ISTH major bleeding criteria. The CHA<sub>2</sub>DS<sub>2</sub>-VASc score was calculated retrospectively by adding two points for age ≥ 75 years and prior stroke, transient ischemic attack (TIA) or thromboembolism, as well as one point for congestive heart failure (defined by left ventricular ejection fraction &lt;50%), arterial hypertension, age between 65–74 years, known diabetes mellitus, prior MI or peripheral artery disease, and female sex, respectively [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>,<a href="#pone.0330164.ref022" class="usa-link" aria-describedby="pone.0330164.ref022">22</a>]. The CHA₂DS₂-VA score was calculated as described [<a href="#pone.0330164.ref013" class="usa-link" aria-describedby="pone.0330164.ref013">13</a>]. Risk categories comprised of a high risk category according to CHA₂DS₂-VASc (≥2 points in men, ≥ 3 points in women or CHA₂DS₂-VASc ≥ 2 points regardless of sex) an intermediate risk category (CHA₂DS₂-VASc = 1 point in men, 2 points in women or CHA₂DS₂-VASc = 1 point regardless of sex) and a low risk category (CHA₂DS₂-VASc = 0 points in men, ≤ 1 point in women, or CHA₂DS₂-VASc = 0 points regardless of sex). For calculation of the hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score, the original CHA<sub>2</sub>DS<sub>2</sub>-VASc score was extended by adding 0 points for hs-cTnT &lt; 5 ng/L, 1 point for hs-cTnT 5–14 ng/L and 2 points for hs-cTnT &gt; 14 ng/L. Throughout the study period, hs-cTnT was measured using the Roche Cobas E411 platform (Roche Diagnostics Ltd., Rotkreuz, Switzerland), with no changes in vendor. Test kits were updated as per manufacturer recommendations over time, but the fundamental analytical platform remained unchanged.</p></section><section id="sec009"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Data is presented as means (standard deviations, SD), medians (25<sup>th</sup>, 75<sup>th</sup> percentiles, IQR), Kaplan-Meier estimates, as well as counts or percentages. For continuous variables the Kolmogorov-Smirnov test was used to test for normal distribution. Subgroups of categorical variables were tested against each other using chi-squared test or Fisher’s exact test. For continuous variables an unpaired Student’s t-test or Wilcoxon rank-sum test was performed. For Kaplan-Meier analysis, subgroups were compared by Log-rank test. The proportional hazards assumption was analyzed by the Grambsch and Therneau method [<a href="#pone.0330164.ref023" class="usa-link" aria-describedby="pone.0330164.ref023">23</a>]. We used time dependent receiver-operating-characteristic (ROC) curves and calculated the area under the ROC curves (AUC) on censored survival data. Here, the 95% confidence interval (CI) was calculated according to Hanley and McNeil [<a href="#pone.0330164.ref024" class="usa-link" aria-describedby="pone.0330164.ref024">24</a>]. For comparison of ROC curves, method by Hanley and McNeil was used as described [<a href="#pone.0330164.ref025" class="usa-link" aria-describedby="pone.0330164.ref025">25</a>]. The incremental prognostic value of adding hs-cTnT to the CHA₂DS₂-VASc score was assessed using the Net Reclassification Index (NRI), following established methodology for survival data [<a href="#pone.0330164.ref026" class="usa-link" aria-describedby="pone.0330164.ref026">26</a>]. A two tailed P-value of &lt;0.05 was considered to indicate statistical significance. Statistical analyses were performed using R software (version 4.3.0, R Foundation for Statistical Computing, Vienna, Austria) as well as MedCalc (Version 20.105. MedCalc Software Ltd, Ostend Belgium).</p></section></section><section id="sec010"><h2 class="pmc_sec_title">Results</h2>
<p>In this study, 227 (2.2%) of initially 10,222 included AF patients within HERA-FIB were excluded for the presence of mechanical prosthetic heart valve(s) or moderate/severe mitral stenosis, resulting in a total of 9,995 included patients with non-valvular AF (<strong><a href="#pone.0330164.g001" class="usa-link">Fig 1</a></strong>). Baseline characteristics are reported, stratified by clinical risk category of CHA<sub>2</sub>DS<sub>2</sub>-VASc score. A total of 455 patients (4.6%) were classified as low-risk, 871 patients (8.7%) as intermediate-risk and 8,669 patients (86.7%) as high-risk (<strong><a href="#pone.0330164.t001" class="usa-link">Table 1</a></strong>). A figure for the distribution of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score among the whole cohort is shown in <a href="#pone.0330164.s001" class="usa-link">S1 Fig</a>. Patients subcategorized using CHA<sub>2</sub>DS<sub>2</sub>-VASc score differed significantly with respect to the baseline variables. The majority of the patients in the intermediate-risk group were male (65.7%), median age was 59 years (IQR 52–64). Within intermediate-risk group, the most frequent comorbidity was arterial hypertension (54.9%), followed by coronary artery disease (6.3%) and former MI (2.3%). A total of 61.1% of patients categorized intermediate-risk by CHA<sub>2</sub>DS<sub>2</sub>-VASc score received an oral anticoagulation (OAC) at discharge. Heart rate at admission was the highest in intermediate-risk category. Cardiac biomarkers such as hs-cTnT showed a steady increase among risk all risk categories.</p>
<section class="tw xbox font-sm" id="pone.0330164.t001"><h3 class="obj_head">Table 1. Baseline characteristics classified by CHA<sub>2</sub>DS<sub>2</sub>-VASc risk category.</h3>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Variables</th>
<th align="left" rowspan="1" colspan="1">Low-risk</th>
<th align="left" rowspan="1" colspan="1">Intermediate-risk</th>
<th align="left" rowspan="1" colspan="1">High-risk</th>
<th align="left" rowspan="1" colspan="1">p-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">Age, y, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">51 (44-57)</td>
<td align="left" rowspan="1" colspan="1">59 (52-64)</td>
<td align="left" rowspan="1" colspan="1">77 (70-83)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sex, male, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">316 (69.5)</td>
<td align="left" rowspan="1" colspan="1">572 (65.7)</td>
<td align="left" rowspan="1" colspan="1">4939 (57.0)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">BMI, kg/m<sup>²</sup>, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">25.8 (23.1-28.6)<br>n = 219</td>
<td align="left" rowspan="1" colspan="1">26.5 (23.6-30.8)<br>n = 494</td>
<td align="left" rowspan="1" colspan="1">26.8 (24.1-30.6)<br>n = 5525</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HF, bpm, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">106 (82-135)</td>
<td align="left" rowspan="1" colspan="1">111 (85-135)</td>
<td align="left" rowspan="1" colspan="1">88 (72-114)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bp<sub>syst</sub>, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">140 (126-152)<br>n = 450</td>
<td align="left" rowspan="1" colspan="1">145 (130-156)<br>n = 863</td>
<td align="left" rowspan="1" colspan="1">147 (131-161)<br>n = 8631</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bp<sub>diast</sub>, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">85 (77-97)<br>n = 450</td>
<td align="left" rowspan="1" colspan="1">89 (79-100)<br>n = 863</td>
<td align="left" rowspan="1" colspan="1">84 (75-96)<br>n = 8629</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Arterial hypertension, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">478 (54.9)</td>
<td align="left" rowspan="1" colspan="1">7756 (89.5)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Diabetes mellitus, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">13 (1.5)</td>
<td align="left" rowspan="1" colspan="1">1983 (22.9)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">History of CAD, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">55 (6.3)</td>
<td align="left" rowspan="1" colspan="1">4253 (29.1)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">History of CABG, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">5 (0.6)</td>
<td align="left" rowspan="1" colspan="1">905 (10.4)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">History of MI, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">0 (0)</td>
<td align="left" rowspan="1" colspan="1">20 (2.3)</td>
<td align="left" rowspan="1" colspan="1">1627 (18.8)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">CHA<sub>2</sub>DS<sub>2</sub>-VASc -score, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">0 (0-1)</td>
<td align="left" rowspan="1" colspan="1">1 (1-2)</td>
<td align="left" rowspan="1" colspan="1">4 (3-5)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">OAC at discharge, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">200 (44.0)</td>
<td align="left" rowspan="1" colspan="1">532 (61.1)</td>
<td align="left" rowspan="1" colspan="1">6201 (71.5)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">No OAC at discharge, n (%<sub>all</sub>)</td>
<td align="left" rowspan="1" colspan="1">255 (56.0)</td>
<td align="left" rowspan="1" colspan="1">339 (38.9)</td>
<td align="left" rowspan="1" colspan="1">2468 (28.5)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">hs-cTnT, ng/L, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">6 (4-10)</td>
<td align="left" rowspan="1" colspan="1">8 (6-15)</td>
<td align="left" rowspan="1" colspan="1">21 (12-41)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hb, g/dl, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">14.8 (13.8-15.7)</td>
<td align="left" rowspan="1" colspan="1">14.5 (13.4-15.5)</td>
<td align="left" rowspan="1" colspan="1">13.0 (11.6-14.3)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Serum creatinine, mg/dl, median (IQR)</td>
<td align="left" rowspan="1" colspan="1">0.85 (0.72-0.99)</td>
<td align="left" rowspan="1" colspan="1">0.89 (0.74-1.03)</td>
<td align="left" rowspan="1" colspan="1">1.01 (0.82-1.34)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330164.t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t001fn001"><p>Abbreviations: AF, atrial fibrillation; BMI, body mass index; bpm, beats per minutes; bp blood pressure; CABG, coronary artery bypass graft; CAD, coronary artery disease; dia, diastolic; Hb, hemoglobin; HF heart frequency; hs-cTnT, highly sensitive cardiac troponin T; MI, myocardial infarction; NT-proBNP, sys, systolic.</p></div></div></section><section id="sec011"><h3 class="pmc_sec_title">Deterioration of adverse events in higher CHA<sub>2</sub>DS<sub>2</sub>-VASc -risk categories</h3>
<p>Outcomes and hazard ratios (HR) classified by risk category of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score are shown in <strong><a href="#pone.0330164.t002" class="usa-link">Table 2</a></strong>. During a median follow-up of 23 months (IQR 12–35), the composite endpoint defined as stroke, MI or all-cause mortality event occurred in 5.3% for low-risk patients, 7.3% for intermediate-risk patients and 28.6% for patients within the high-risk category. A Kaplan-Meier analysis classified by CHA<sub>2</sub>DS<sub>2</sub>-VASc-risk category for the composite endpoint is shown in <strong><a href="#pone.0330164.g002" class="usa-link">Fig 2</a></strong>. Here, patients within the intermediate-risk category showed an HR of 1.43 (95%CI: 1.16–1.76, p &lt; 0.0001) for an adverse outcome compared to low-risk category and an HR of 4.53 (95%CI: 3.97–5.15, p &lt; 0.0001) for an adverse outcome compared to high-risk category. Compared to patients with low-risk, patients within the intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc-risk category had an HR of 2.39 (95% CI: 1.28–4.47, p &lt; 0.0001) for stroke and an HR of 3.73 (95%CI: 2.31–6.03, p &lt; 0.0001) for a major bleeding event. Kaplan-Meier analyses for separate outcome parameters and other outcomes recorded within HERA-FIB, such as all-cause mortality, stroke, major bleeding and myocardial infarction (MI) stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk category is shown in <a href="#pone.0330164.s002" class="usa-link">S2 Fig</a>.</p>
<section class="tw xbox font-sm" id="pone.0330164.t002"><h4 class="obj_head">Table 2. Outcomes and HR classified by CHA<sub>2</sub>DS<sub>2</sub>-VASc risk category.</h4>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
<col align="left" valign="middle" span="1">
</colgroup>
<thead><tr>
<th align="left" rowspan="1" colspan="1">Variables</th>
<th align="left" rowspan="1" colspan="1">Low-risk</th>
<th align="left" rowspan="1" colspan="1">Intermediate-risk</th>
<th align="left" rowspan="1" colspan="1">High-risk</th>
<th align="left" rowspan="1" colspan="1">p-value</th>
</tr></thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Composite EP</strong><a href="#t002fn001" class="usa-link"><sup>*</sup></a><strong>, n (%</strong><sub><strong>all</strong></sub>)</td>
<td align="left" rowspan="1" colspan="1">24 (5.3)</td>
<td align="left" rowspan="1" colspan="1">64 (7.3)</td>
<td align="left" rowspan="1" colspan="1">2476 (28.6)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HR (95%CI)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.43 (1.16-1.76)</td>
<td align="left" rowspan="1" colspan="1">6.45 (5.42-7.67)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Stroke, n (%</strong><sub><strong>all</strong></sub>)</td>
<td align="left" rowspan="1" colspan="1">2 (0.5)</td>
<td align="left" rowspan="1" colspan="1">9 (1.2)</td>
<td align="left" rowspan="1" colspan="1">271 (3.7)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">2.39 (1.28-4.47)</td>
<td align="left" rowspan="1" colspan="1">8.50 (5.04-14.32)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>MI, n (%</strong><sub><strong>all</strong></sub>)</td>
<td align="left" rowspan="1" colspan="1">5 (1.2)</td>
<td align="left" rowspan="1" colspan="1">8 (1.0)</td>
<td align="left" rowspan="1" colspan="1">364 (5.0)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HR (95%CI)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">0.85 (0.50-1.46)</td>
<td align="left" rowspan="1" colspan="1">4.67 (3.00-7.31)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>All-cause mortality, n (%</strong><sub><strong>all</strong></sub>)</td>
<td align="left" rowspan="1" colspan="1">18 (4.0)</td>
<td align="left" rowspan="1" colspan="1">49 (5.6)</td>
<td align="left" rowspan="1" colspan="1">2038 (23.5)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">1.45 (1.15-1.83)</td>
<td align="left" rowspan="1" colspan="1">6.88 (5.66-8.35)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
<strong>Major bleeding, n (%</strong><sub><strong>all</strong></sub>)</td>
<td align="left" rowspan="1" colspan="1">3 (0.7)</td>
<td align="left" rowspan="1" colspan="1">21 (2.7)</td>
<td align="left" rowspan="1" colspan="1">456 (6.2)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">HR (95% CI)</td>
<td align="left" rowspan="1" colspan="1"></td>
<td align="left" rowspan="1" colspan="1">3.73 (2.31-6.03)</td>
<td align="left" rowspan="1" colspan="1">9.53 (6.38-14.21)</td>
<td align="left" rowspan="1" colspan="1">&lt;0.0001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/pone.0330164.t002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="t002fn001"><p>* the composite EP consisted of stroke, MI or all-cause mortality, p-value was calculated as p-value for trend and log rank test for HRs. Abbreviations: CI, confidence interval; HR, hazard ratio; MI, myocardial infarction.</p></div></div></section><figure class="fig xbox font-sm" id="pone.0330164.g002"><h4 class="obj_head">Fig 2. Kaplan Meier analysis for composite endpoint consisting of stroke, MI or all-cause mortality showed an increase in outcomes stratified by CHA<sub>2</sub>DS<sub>2</sub>-VASc risk category.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370022_pone.0330164.g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce36/12370022/314dfb6596ae/pone.0330164.g002.jpg" loading="lazy" height="506" width="682" alt="Fig 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330164.g002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Patients within higher risk categories of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score showed a higher probability for the composite endpoint. Abbreviations: EP, endpoint.</p></figcaption></figure></section><section id="sec012"><h3 class="pmc_sec_title">Modest prognostic performance of CHA<sub>2</sub>DS<sub>2</sub>-VASc score</h3>
<p>For the entire cohort, the AUC for the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in prediction of the composite endpoint was 0.648 (95%CI: 0.638–0.657, p &lt; 0.0001). For the individual components of the composite endpoint, CHA<sub>2</sub>DS<sub>2</sub>-VASc score showed only a modest performance with an AUC of 0.623 (95%CI: 0.612–0.633, p &lt; 0.0001) for stroke, an AUC of 0.632 (95%CI: 0.621–0.642, p &lt; 0.0001) for MI and an AUC of 0.643 (95%CI: 0.634–0.652, p &lt; 0.0001) for all-cause mortality. For major bleeding events, AUC of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score was 0.604 (95%CI: 0.594–0.615, p &lt; 0.0001) for the entire cohort.</p></section><section id="sec013"><h3 class="pmc_sec_title">Improved prediction of adverse outcomes adding hs-cTnT</h3>
<p>Since the CHA<sub>2</sub>DS<sub>2</sub>-VASc score showed only a modest performance in prediction of the composite endpoint, we thought to evaluate the role of a biomarker enhanced risk score utilizing hs-cTnT. For the prediction of the composite endpoint, hs-cTnT alone showed an AUC of 0.745 (95%CI: 0.737–0.754, p &lt; 0.0001) within the entire study cohort. AUCs for hs-cTnT separated for the individual endpoints are shown in <a href="#pone.0330164.s005" class="usa-link">S1 Table</a>. A Kaplan-Meier analysis for the composite endpoint and hs-cTnT categories is shown in <strong><a href="#pone.0330164.g003" class="usa-link">Fig 3A</a></strong>. HRs for the composite endpoint increased among hs-cTnT categories. Compared to patients with hs-cTnT serum levels &lt;5 ng/L, patients with a hs-cTnT serum level between 5–14 ng/L had a HR of 4.06 (95%CI: 3.45–4.79) for the composite endpoint. In patients with hs-cTnT serum level &gt;14 ng/L, HR for the composite endpoint was 17.19 (95%CI: 14.65–20.18), respectively. Kaplan-Meier analyses separated for available outcomes classified by hs-cTnT levels (hs-cTnT &lt; 5 ng/l, hs-cTnT 5–14 ng/L and hs-cTnT &gt; 14 ng/L) are shown in <a href="#pone.0330164.s003" class="usa-link">S3 Fig</a>. To quantify the incremental predictive value of hs-cTnT when added to the CHA₂DS₂-VASc score, we calculated the NRI, which was 0.83 (95% CI: 0.56–0.98; p = 0.0099), indicating substantial improvement in risk stratification for adverse outcomes.</p>
<figure class="fig xbox font-sm" id="pone.0330164.g003"><h4 class="obj_head">Fig 3. Kaplan Meier analysis for the composite endpoint stratified by hs-cTnT categories for the entire cohort (A) and patients in intermediate-risk category according to CHA<sub>2</sub>DS<sub>2</sub>-VASc score (B).</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12370022_pone.0330164.g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce36/12370022/4ce63c963efb/pone.0330164.g003.jpg" loading="lazy" height="285" width="767" alt="Fig 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/pone.0330164.g003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Abbreviations: EP, endpoint; hs-cTnT, highly sensitive cardiac troponin T.</p></figcaption></figure></section><section id="sec014"><h3 class="pmc_sec_title">Improvement of risk prediction by adding hs-cTnT in intermediate-risk AF patients</h3>
<p>In AF patients with intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc, AUC of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in prediction of the composite endpoint was 0.542 (95%CI: 0.508–0.575, p = 0.2487). Instrumenting hs-cTnT serum levels for risk prediction in patients with intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc score showed a significantly higher AUC for the prediction of the composite endpoint of 0.778 (95%CI: 0.748–0.805), ∆AUC 0.236 (95%CI 0.146–0.325, p &lt; 0.001). Kaplan Meier analysis for patients within the intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc category, stratified by hs-cTnT categories (hs-cTnT &lt; 5 ng/l, hs-cTnT 5–14 ng/L and hs-cTnT &gt; 14 ng/L) is shown in <a href="#pone.0330164.g003" class="usa-link">Fig 3B</a>. In patients with undetectable hs-cTnT serum levels, i.e., values below the limit of detection (LoD) &lt;5 ng/L, no composite endpoint event occurred, whereas rates of the composite endpoint increased gradually from 4.87% in patients with hs-cTnT of 5–14 ng/L to 17.41% in those with hs-cTnT serum levels &gt;14 ng/L. Accordingly, HR for patients with hs-cTnT serum levels of &gt;14 ng/L compared to patients with hs-cTnT serum levels 5–14 ng/L was 3.92 (95%CI: 2.16–7.09, p &lt; 0.0001). Consistently, the addition of hs-cTnT to the CHA₂DS₂-VASc score in intermediate-risk patients significantly improved risk classification, as reflected by a NRI of 0.24 (95% CI: 0.12–0.47; p &lt; 0.0001).</p></section><section id="sec015"><h3 class="pmc_sec_title">Prediction of the composite endpoint in patients with intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc score treated with oral anticoagulants</h3>
<p>Among 871 patients within the intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc category, a total of 532 (61.1%) patients were treated with oral anticoagulants. In OAC treated patients, AUC CHA<sub>2</sub>DS<sub>2</sub>-VASc score in prediction of the composite endpoint was 0.515 (95%CI: 0.472–0.558, p = 0.7958). For stroke prediction AUC was 0.572 (95%CI: 0.526–0.617, p = 0.5974) and for the prediction of a major bleeding event AUC was 0.641 (95%CI: 0.596–0.684, p = 0.0782). However, when hs-cTnT was added, AUC improved to 0.755 (95%CI: 0.716–0.791), p &lt; 0.0001 in prediction of the composite endpoint.</p></section><section id="sec016"><h3 class="pmc_sec_title">Prediction of the composite endpoint in patients with intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc score not treated with oral anticoagulants</h3>
<p>In 38.9% of AF patients not treated with oral anticoagulants and categorized as intermediate risk per CHA<sub>2</sub>DS<sub>2</sub>-VASc, AUC for the CHA<sub>2</sub>DS<sub>2</sub>-VASc score in prediction of the composite endpoint was 0.559 (95%CI: 0.504–0.613, p = 0.2076). However, when hs-cTnT was added, AUC significantly improved to 0.808 (95%CI: 0.62–0.848, p &lt; 0.0001) for prediction of the composite endpoint.</p></section><section id="sec017"><h3 class="pmc_sec_title">Comparison of CHA₂DS₂-VASc to CHA₂DS₂-VA in risk assessment of patients within the intermediate risk group</h3>
<p>According to the CHA₂DS₂-VASc score, 871 patients were classified as intermediate risk (1 point in men, 2 points in women). However, reclassification using the CHA₂DS₂-VA score resulted in a different distribution of risk groups, with 564 patients (5.6%) classified as low risk, 967 patients (9.7%) as intermediate risk, and 8,464 patients (84.7%) as high risk within the HERA-FIB cohort. As a result, the distribution of outcome parameters across risk categories differed between the two scoring models, as detailed in <a href="#pone.0330164.s006" class="usa-link">S2 Table</a>. For the entire cohort, the CHA₂DS₂-VA score showed limited discriminatory ability for predicting the composite endpoint (AUC: 0.650, 95% CI: 0.641–0.660, p &lt; 0.0001). A summary of AUC values for all outcome parameters is provided in <a href="#pone.0330164.s007" class="usa-link">S3 Table</a>. Among patients with an intermediate CHA₂DS₂-VA score, the predictive value for the composite endpoint was poor (AUC: 0.509, 95% CI: 0.475–0.542, p = 0.8185). However, when hs-cTnT was incorporated within patients with intermediate CHA₂DS₂-VA score, the predictive performance significantly improved, with an AUC of 0.778 (95% CI: 0.750–0.803, p &lt; 0.0001). A Kaplan-Meier analysis for the composite endpoint in intermediate-risk patients per CHA₂DS₂-VA score is shown in <a href="#pone.0330164.s004" class="usa-link">S4 Fig</a>. Among the 967 patients classified as intermediate risk by CHA₂DS₂-VA, 611 (63.2%) received OAC, while 356 (36.8%) remained without OAC treatment. For the prediction of the composite endpoint, the CHA₂DS₂-VA score alone showed poor discrimination in both OAC-treated patients (AUC: 0.500, 95% CI: 0.460–0.540) and non-OAC patients (AUC: 0.500, 95% CI: 0.447–0.553). However, the addition of hs-cTnT significantly improved risk prediction, showing an AUC of 0.733 (95% CI: 0.696–0.767, p &lt; 0.0001) in OAC-treated patients and 0.825 (95% CI: 0.782–0.863, p &lt; 0.0001) in non-OAC patients.</p></section><section id="sec018"><h3 class="pmc_sec_title">Risk assessment using a novel hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score</h3>
<p>Considering that serum levels of hs-cTnT &gt; 5 ng/L and hs-cTnT &gt; 14 ng/L remained independent predictors for the composite endpoint in patients with intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc score, we evaluated an extension of the original score by adding 0 points for hs-cTnT &lt; 5 ng/L, 1 point for hs-cTnT 5–14 ng/L and 2 points for hs-cTnT &gt; 14 ng/L. The median for hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score in patients within the intermediate risk category was 2 points (IQR 2–3).</p>
<p>Importantly, no events were observed in intermediate risk patients with hs-cTnT &lt; 5 ng/L, while the event rate increased to 5.0% in the 5–14 ng/L group and reached 17.5% in those with hs-cTnT &gt; 14 ng/L, indicating a clear gradient of risk across hs-cTnT strata.</p>
<p>In all patients, a comparison between the original CHA<sub>2</sub>DS<sub>2</sub>VASc score and the hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score in prediction of the composite endpoint revealed an AUC of 0.647 (95%CI 0.638–0.657) for the original CHA<sub>2</sub>DS<sub>2</sub>VASc-score and an AUC of 0.683 (95%CI 0.674–0.692) for the hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score, ∆AUC 0.0358 (95%CI 0.0325–0.0390, p &lt; 0.0001). In patients with oral anticoagulants and an intermediate CHA<sub>2</sub>DS<sub>2</sub>-VASc score, AUC for hs-cTnCHA2DS2VASc-score in prediction of the composite endpoint was 0.683 (95%CI: 0.642–0.723) showing a ∆AUC of 0.168 (95%CI: 0.0767–0.260, p = 0.0003) in comparison to the original CHA<sub>2</sub>DS<sub>2</sub>-VASc score. In intermediate risk patients without oral anticoagulants AUC for hs-cTnCHA2DS2VASc-score in prediction of the composite endpoint was 0.686 (95%CI: 0.631–0.732, ∆AUC in comparison to the original CHA<sub>2</sub>DS<sub>2</sub>-VASc score was 0.124 (95%CI: 0.0367–0.212, p = 0.0054).</p></section></section><section id="sec019"><h2 class="pmc_sec_title">Discussion</h2>
<p>This study sought to investigate whether hs-cTnT might improve prediction of a composite endpoint including stroke, MI and all-cause mortality in AF patients at an intermediate-risk according to the CHA<sub>2</sub>DS<sub>2</sub>-VASc score. The later has only modest performance for prediction of the composite endpoint and does not help for the decision whether AF patients at intermediate risk should receive an anticoagulation. Our findings show that the addition of hs-cTnT to the CHA<sub>2</sub>DS<sub>2</sub>-VASc score improves the prediction of the composite endpoint in AF patients presenting in the setting of an ED. A unique finding of our study is that patients with undetectable hs-cTnT represent a very low risk cohort in respective to stroke, MI or all-cause mortality.</p>
<p>In order to identify appropriate candidates for oral anticoagulation, guidelines on management of AF recommend a clinical risk-factor based assessment for prediction of stroke and major bleeding events [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>]. However, scoring systems recommended by guidelines show only a modest performance and fail to provide clear recommendations on important subgroups of patients, such as patients with intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc score (men: 1 point, women: 2 points) [<a href="#pone.0330164.ref007" class="usa-link" aria-describedby="pone.0330164.ref007">7</a>,<a href="#pone.0330164.ref022" class="usa-link" aria-describedby="pone.0330164.ref022">22</a>,<a href="#pone.0330164.ref027" class="usa-link" aria-describedby="pone.0330164.ref027">27</a>]. Beyond its use in AF-related thromboembolic risk stratification, emerging evidence highlights that the CHA₂DS₂-VASc score has broader prognostic utility in cardiovascular conditions. Studies have demonstrated its predictive value for major adverse cardiovascular events (MACE) in patients with coronary artery disease (CAD), acute coronary syndrome (ACS), and even in individuals without AF. For example, Hioki et al. [<a href="#pone.0330164.ref028" class="usa-link" aria-describedby="pone.0330164.ref028">28</a>] showed that the CHA₂DS₂-VASc score effectively stratifies risk in patients undergoing percutaneous coronary intervention (PCI), while Sen et al. [<a href="#pone.0330164.ref029" class="usa-link" aria-describedby="pone.0330164.ref029">29</a>] found its association with cardiovascular mortality and MACE in ACS patients. Furthermore, it has been applied to non-thromboembolic cardiovascular risks, including mortality in hospitalized cardiovascular patients and even pneumonia-related cardiovascular events. Lee et al. [<a href="#pone.0330164.ref030" class="usa-link" aria-describedby="pone.0330164.ref030">30</a>] demonstrated its relevance in predicting hospital readmission rates among patients receiving tele-health monitoring, while Wang et al. [<a href="#pone.0330164.ref031" class="usa-link" aria-describedby="pone.0330164.ref031">31</a>] showed that it stratifies MACE risk in pneumonia patients. Additionally, Cheng et al. [<a href="#pone.0330164.ref032" class="usa-link" aria-describedby="pone.0330164.ref032">32</a>] validated its prognostic role in PAD patients undergoing angioplasty.</p>
<p>The 2024 ESC Guidelines now recommend the use of the CHA₂DS₂-VA score instead of CHA₂DS₂-VASc for thromboembolic risk stratification in AF patients [<a href="#pone.0330164.ref013" class="usa-link" aria-describedby="pone.0330164.ref013">13</a>]. However, the role of sex as a risk factor in anticoagulation decision-making remains controversial. Large population-based studies have yielded conflicting results regarding the predictive superiority of CHA₂DS₂-VA over CHA₂DS₂-VASc [<a href="#pone.0330164.ref033" class="usa-link" aria-describedby="pone.0330164.ref033">33</a>]. For example, an analysis of UK primary and secondary care data from 195,719 AF patients found that removing female sex from the CHA₂DS₂-VASc score did not reduce its ability to discriminate thromboembolic events, challenging the necessity of this adjustment [<a href="#pone.0330164.ref034" class="usa-link" aria-describedby="pone.0330164.ref034">34</a>]. In our cohort, we compared both risk scores in patients classified as intermediate risk. We found that the predictive ability of CHA₂DS₂-VA for stroke, MI and all-cause mortality remained poor in patients at intermediate risk (AUC: 0.509, 95% CI: 0.475–0.542 p = 1.00), similar to CHA₂DS₂-VASc. However, when hs-cTnT was incorporated, predictive performance significantly improved for both scores, irrespective of oral anticoagulation. Specifically, the AUC for the composite endpoint increased to 0.778 (95% CI: 0.750–0.803, p &lt; 0.0001). The improvement was observed both in patients receiving OAC and in those not treated with anticoagulation, with a more pronounced effect in non-OAC patients. These findings highlight the limitations of both CHA₂DS₂-VASc and CHA₂DS₂-VA in risk stratification for intermediate-risk AF patients and suggest that biomarker-enhanced models such as hs-cTnT could improve risk assessment in clinical routine. Given that guideline recommendations remain uncertain in this subgroup, the integration of hs-cTnT may help individualize anticoagulation strategies in patients who otherwise fall into a risk “gray zone”. Our results reveal that patients classified as intermediate-risk based on the CHA<sub>2</sub>DS<sub>2</sub>-VASc score had a significantly higher HR for adverse outcomes when compared to low-risk patients. Limitations of the CHA<sub>2</sub>DS<sub>2</sub>-VASc score prevail across all risk categories but individualization of therapy has the highest clinical relevance among patients at intermediate risk, where clear recommendations for the initiation of anticoagulation are missing. Here, we could show a more accurate discrimination of risk assessment by integrating hs-cTnT serum levels in risk prediction for stroke, MI and all-cause mortality. The significant increase in HR, as hs-cTnT levels rose indicates its potential as a valuable biomarker for refining risk stratification in AF patients. The most relevant finding is that patients with undetectable hs-cTnT represent a cohort at very low risk experiencing no adverse outcome events of stroke, MI or all-cause mortality during follow-up. In fact, within the intermediate-risk group, no events occurred in patients with hs-cTnT &lt; 5 ng/L, whereas the event rate for the composite outcome (stroke, MI, and all-cause mortality) increased to 5.0% in those with hs-cTnT between 5–14 ng/L and reached 17.5% in those with hs-cTnT &gt; 14 ng/L, showing a clear, step wise increase in adverse outcomes. These findings suggest that intermediate-risk patients with hs-cTnT &lt; 5 ng/L represent a cohort of extremely low risk for adverse events. The present study contributes to the continuous evolution of risk stratification in AF patients presenting to an emergency department. Historically, stroke risk prediction models, including CHA₂DS₂-VASc, were developed in cohorts of untreated AF patients. However, in contemporary practice, stroke risk in AF represents a mixture of residual risk despite OAC and the true risk in untreated patients. As Lip et al. (2023) emphasize, interpreting stroke risk in modern AF cohorts must account for the impact of anticoagulation use. [<a href="#pone.0330164.ref035" class="usa-link" aria-describedby="pone.0330164.ref035">35</a>] In our study, 61% of intermediate-risk patients received OAC, while 39% remained untreated, reflecting this dual-risk profile. Thus, even when separated by OAC or non-OAC therapy, the addition of hs-cTnT to the CHA<sub>2</sub>DS<sub>2</sub>-VASc score added relevant predictive information for the composite endpoint of stroke, MI and all-cause mortality</p>
<p>Given the broad cardiovascular implications of the CHA₂DS₂-VASc score, the use of a composite endpoint consisting of stroke, MI and all-cause mortality our study is justified. Previous studies have shown that ischemic and hemorrhagic risks are closely interlinked, as seen in patients with CAD, heart failure, and peripheral artery disease. Thus, incorporating both stroke and major bleeding into the risk assessment provides a more holistic approach to patient management.</p>
<p>The reasons why hs-cTn allows prediction of adverse outcomes in AF patients is not fully understood but most likely multifactorial as cardiac troponin summarizes the cumulative impact of comorbidities that trigger myocardial injury. In agreement with previous observations bleeding risk is closely linked to ischemic risk [<a href="#pone.0330164.ref036" class="usa-link" aria-describedby="pone.0330164.ref036">36</a>–<a href="#pone.0330164.ref039" class="usa-link" aria-describedby="pone.0330164.ref039">39</a>]. A subanalysis from the RE-LY study (Randomized Evaluation of Long-Term Anticoagulation Therapy), which was initially designed to investigate the appropriateness of dabigatran in comparison of warfarin, investigated the role of elevated cardiac troponin I in a preselected cohort of patients with new onset AF and found that cTnI serum levels were indepenently related to stroke [<a href="#pone.0330164.ref040" class="usa-link" aria-describedby="pone.0330164.ref040">40</a>]. However, the authors could not provide data on cTnT. Moreover, the RE-LY trial did not provide information for patients in real-world and particularly in the setting of admission to an ED. The hypothesis that biomarkers might improve prediction of adverse outcomes including stroke and adverse outcomes is not novel. Previously, Hijazi et al. introduced and validated the ABC score, a risk assessment tool that incorporates clinical information and biomarkers [<a href="#pone.0330164.ref009" class="usa-link" aria-describedby="pone.0330164.ref009">9</a>]. While prediction of adverse outcomes was improved, the implementation into clinical routine lags behind expectations outside randomized trials. The combination of the established CHA<sub>2</sub>DS<sub>2</sub>VASc-score with the single broadly available hs-cTnT or hs-cTnI which is used as a dichotomous variable is more convenient and more likely to be adopted in routine. However, future external validation of this combined risk assessment strategy is required before our findings will help to individualize anticoagulation in AF patients at intermediate stroke risk.</p>
<p>Our study introduces the hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score as a novel predictive tool for assessing the combined endpoint of stroke, MI and all-cause mortality in AF patients with intermediate-risk in CHA<sub>2</sub>DS<sub>2</sub>-VASc score. Despite being widely used in clinical routine, our study underscores the modest performance of CHA<sub>2</sub>DS<sub>2</sub>-VASc score emphasizing the need for innovative and simple approaches to improve risk prediction in AF patients presenting in the acute setting of an ED. Particularly, the enhanced predictive value of hs-cTnT aligns with previous research suggesting that biomarkers – especially cardiac biomarkers – as demonstrated by studies [<a href="#pone.0330164.ref014" class="usa-link" aria-describedby="pone.0330164.ref014">14</a>–<a href="#pone.0330164.ref016" class="usa-link" aria-describedby="pone.0330164.ref016">16</a>,<a href="#pone.0330164.ref026" class="usa-link" aria-describedby="pone.0330164.ref026">26</a>,<a href="#pone.0330164.ref041" class="usa-link" aria-describedby="pone.0330164.ref041">41</a>], may significantly contribute to risk stratification for AF patients. Notably, the inclusion of hs-cTnT significantly enhances the discriminatory power of the risk assessment tool, within the intermediate-risk CHA<sub>2</sub>DS<sub>2</sub>-VASc-category. Beyond improvements in discrimination, we also evaluated reclassification performance. For the whole cohort, adding hs-cTnT to the CHA₂DS₂-VASc score resulted in an NRI of 0.83 (95% CI: 0.56–0.98; p = 0.0099), indicating substantial improvement in risk categorization. Among intermediate-risk patients, the NRI was 0.24 (95% CI: 0.12–0.47; p &lt; 0.0001), reflecting clinically meaningful reclassification within this “gray-zone” population. This underscores the clinical value of hs-cTnT in refining risk assessment for AF patients, particularly in the intermediate-risk group, potentially offering a more precise basis for decisions regarding anticoagulation therapy. Moreover, given the increasing use of CHA₂DS₂-VASc in cardiovascular risk assessment beyond AF, our study provides further insights into how this score can be adapted for broader clinical applications.</p></section><section id="sec020"><h2 class="pmc_sec_title">Limitations and future directions</h2>
<p>It is important to acknowledge the limitations of our study. First, our findings were derived from a single tertiary referral center at an academic center in Germany and may not be generalized to other geographic regions or health care systems. Second, our findings on the predictive role of hs-cTnT alone and particularly the novel hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score still requires prospective validation in independent populations. Third, our findings are based exclusively on hs-cTnT and no blood specimen are available for evaluation of other hs-cTnI assays. Fourth, the relatively short median follow-up duration of 23 months may not fully capture the long-term effects of risk assessment using the hs-cTnCHA<sub>2</sub>DS<sub>2</sub>VASc-score. Fifth, we studied the added value of hs-cTnT when combined with the CHA<sub>2</sub>DS<sub>2</sub>-VASc score but did not evaluate other risk prediction models such as the ABC score which already contains biomarkers. Finally, temporal changes in patient management and healthcare practices have changed over the study period, spanning from June 2009 to March 2020. In particular, we cannot exclude that changes in demographic characteristics such as age, as well as the increasing preference of DOAC versus VKA may have an impact on risk of stroke and other outcomes in contemporary clinical practice. Within HERA-FIB, the majority of patients were stratified as high risk per CHA₂DS₂-VASc. However, the current analysis focused exclusively on patients with intermediate risk, as they represent the subgroup where clinical decision-making regarding anticoagulation therapy and risk stratification remains most uncertain. While our findings show that hs-cTnT improves risk stratification in this population, an important area for future research will be the refinement of risk assessment strategies in high-risk patients. Additional studies should evaluate whether biomarker-based models, such as the hs-cTnT-enhanced CHA₂DS₂-VASc score, could provide further prognostic discrimination within the high-risk category and identify subgroups with particularly elevated or lower risk within this population.</p></section><section id="sec021"><h2 class="pmc_sec_title">Conclusions</h2>
<p>In conclusion, in patients with AF and intermediate thromboembolic risk, the decision to initiate oral anticoagulation remains uncertain due to the modest predictive performance of current risk scores. Our study shows that adding hs-cTnT to the CHA₂DS₂-VASc score substantially improves risk stratification for adverse cardiovascular outcomes, including stroke, myocardial infarction, and all-cause mortality, particularly within this intermediate-risk population. Importantly, no events occurred in intermediate-risk patients with hs-cTnT levels below the limit of detection, whereas the event rate increased stepwise in patients with elevated hs-cTnT. The addition of hs-cTnT yielded a significant net reclassification improvement in this group, supporting its potential role in risk stratification. In conclusion, our study shows a strong value of hs-cTnT when added to the CHA₂DS₂-VASc score These findings highlight the promise of a biomarker-enhanced CHA₂DS₂-VASc score for individualized risk assessment in AF patients at intermediate risk. However, prospective validation in independent cohorts is needed before clinical implementation.</p></section><section id="sec022"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="pone.0330164.s001"><div class="caption p">
<span>S1 Fig. Distribution of CHA<sub>2</sub>DS<sub>2</sub>-VASc score across the entire cohort.</span><p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s001.tif</a><sup> (247.9KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s002"><div class="caption p">
<span>S2 Fig. Kaplan-Meier analysis for all-cause mortality, stroke, major bleeding and myocardial infarction classified by CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk category.</span><p>Patients with a high-risk category according to CHA<sub>2</sub>DS<sub>2</sub>VASc-score had a higher all-cause mortality (A), a higher probability of ischemic stroke rate (B), a higher probability of major bleeding events (C) and higher risk for myocardial infarction (D). Abbreviatons: MI, myocardial infarction.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s002.tif</a><sup> (890.3KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s003"><div class="caption p">
<span>S3 Fig. Kaplan-Meier analysis for all-cause mortality, stroke, major bleeding and myocardial infarction classified by hs-cTnT category.</span><p>Patients with a high hs-cTnT had a higher all-cause mortality (A), a higher probability of ischemic stroke (B), a higher probability of major bleeding (C) and higher risk for myocardial infarction (D). Abbreviations: MI, myocardial infarction, hs-cTnT, highly sensitive cardiac troponin T.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s003.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s003.tif</a><sup> (745.6KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s004"><div class="caption p">
<span>S4 Fig. Kaplan Meier analysis for the composite endpoint stratified by hs-cTnT categories for patients in intermediate-risk category according to CHA<sub>2</sub>DS<sub>2</sub>-VA score.</span><p>Abbreviations: EP, endpoint; hs-cTnT, highly sensitive cardiac troponin T.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s004.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s004.tif</a><sup> (421.2KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s005"><div class="caption p">
<span>S1 Table. AUC analysis for hs-cTnT in predicting outcome variables. Abbreviations: AUC, area under the curve, CI, confidence interval.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s005.docx</a><sup> (12.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s006"><div class="caption p">
<span>S2 Table. Outcomes and HR classified by CHA₂DS₂-VA risk category.</span><p>*The composite EP consisted of stroke or major bleeding, p-value was calculated as p-value for trend and log rank test for HRs. Abbreviations: CI, confidence interval; HR, hazard ratio; MI, myocardial infarction.</p>
<p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s006.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s006.docx</a><sup> (14.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="pone.0330164.s007"><div class="caption p">
<span>S3 Table. AUCs of the CHA<sub>2</sub>DS<sub>2</sub>VA score separated for outcome variables.</span><p>*The composite EP consisted of stroke and major bleeding events. Abbreviations: AUC, area under the curve, CI, confidence interval, EP endpoint.</p>
<p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s007.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s007.docx</a><sup> (12.9KB, docx) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Data Availability</h2>
<p>The data for this study was retrospectively collected from routine care of consecutive patients admitted to the emergency department. The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg without requiring informed consent. However, patient-level data cannot be shared publicly as informed consent is required for such sharing, which is not feasible in this context. For inquiries regarding the data, the study group of cardiac biomarkers at the Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, can provide assistance. Requests will be handled in accordance with the study protocol and relevant regulations (e.g. the Declaration of Helsinki (2008) and General Data Protection Regulation (EU) 2016/679). Address for correspondence: Study Group Cardiac Biomarkers, Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; E-mail: <span>Giannitsis.Studienbuero@med.uni-heidelberg.de</span>.</p></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>The study was supported by a research grant from Daiichi Sankyo and Bayer diagnostics. The sponsor had no influence on the study concept, data collection, or interpretation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="pone.0330164.ref001">
<span class="label">1.</span><cite>Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke. 1991;22(8):983–8. doi: 10.1161/01.str.22.8.983

</cite> [<a href="https://doi.org/10.1161/01.str.22.8.983" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1866765/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stroke&amp;title=Atrial%20fibrillation%20as%20an%20independent%20risk%20factor%20for%20stroke:%20the%20Framingham%20Study&amp;author=PA%20Wolf&amp;author=RD%20Abbott&amp;author=WB%20Kannel&amp;volume=22&amp;issue=8&amp;publication_year=1991&amp;pages=983-8&amp;pmid=1866765&amp;doi=10.1161/01.str.22.8.983&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref002">
<span class="label">2.</span><cite>Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019;139(10):e56–528. doi: 10.1161/CIR.0000000000000659

</cite> [<a href="https://doi.org/10.1161/CIR.0000000000000659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30700139/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Heart%20Disease%20and%20Stroke%20Statistics-2019%20Update:%20A%20Report%20From%20the%20American%20Heart%20Association&amp;author=EJ%20Benjamin&amp;author=P%20Muntner&amp;author=A%20Alonso&amp;author=MS%20Bittencourt&amp;author=CW%20Callaway&amp;volume=139&amp;issue=10&amp;publication_year=2019&amp;pmid=30700139&amp;doi=10.1161/CIR.0000000000000659&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref003">
<span class="label">3.</span><cite>Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby JV, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med. 2003;349(11):1019–26. doi: 10.1056/NEJMoa022913

</cite> [<a href="https://doi.org/10.1056/NEJMoa022913" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12968085/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Effect%20of%20intensity%20of%20oral%20anticoagulation%20on%20stroke%20severity%20and%20mortality%20in%20atrial%20fibrillation&amp;author=EM%20Hylek&amp;author=AS%20Go&amp;author=Y%20Chang&amp;author=NG%20Jensvold&amp;author=LE%20Henault&amp;volume=349&amp;issue=11&amp;publication_year=2003&amp;pages=1019-26&amp;pmid=12968085&amp;doi=10.1056/NEJMoa022913&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref004">
<span class="label">4.</span><cite>Bode W, Ptaszek LM. Management of Atrial Fibrillation in the Emergency Department. Curr Cardiol Rep. 2021;23(12):179. doi: 10.1007/s11886-021-01611-2

</cite> [<a href="https://doi.org/10.1007/s11886-021-01611-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34657210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Cardiol%20Rep&amp;title=Management%20of%20Atrial%20Fibrillation%20in%20the%20Emergency%20Department&amp;author=W%20Bode&amp;author=LM%20Ptaszek&amp;volume=23&amp;issue=12&amp;publication_year=2021&amp;pages=179&amp;pmid=34657210&amp;doi=10.1007/s11886-021-01611-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref005">
<span class="label">5.</span><cite>Deshmukh A, Iglesias M, Khanna R, Beaulieu T. Healthcare utilization and costs associated with a diagnosis of incident atrial fibrillation. Heart Rhythm O2. 2022;3(5):577–86. doi: 10.1016/j.hroo.2022.07.010

</cite> [<a href="https://doi.org/10.1016/j.hroo.2022.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9626881/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36340482/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Rhythm%20O2&amp;title=Healthcare%20utilization%20and%20costs%20associated%20with%20a%20diagnosis%20of%20incident%20atrial%20fibrillation&amp;author=A%20Deshmukh&amp;author=M%20Iglesias&amp;author=R%20Khanna&amp;author=T%20Beaulieu&amp;volume=3&amp;issue=5&amp;publication_year=2022&amp;pages=577-86&amp;pmid=36340482&amp;doi=10.1016/j.hroo.2022.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref006">
<span class="label">6.</span><cite>Milman B, Burns BD. Atrial fibrillation: an approach to diagnosis and management in the emergency department. Emerg Med Pract. 2021;23(5):1–28. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/33885254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Emerg%20Med%20Pract&amp;title=Atrial%20fibrillation:%20an%20approach%20to%20diagnosis%20and%20management%20in%20the%20emergency%20department&amp;author=B%20Milman&amp;author=BD%20Burns&amp;volume=23&amp;issue=5&amp;publication_year=2021&amp;pages=1-28&amp;pmid=33885254&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref007">
<span class="label">7.</span><cite>Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612

</cite> [<a href="https://doi.org/10.1093/eurheartj/ehaa612" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32860505/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=2020%20ESC%20Guidelines%20for%20the%20diagnosis%20and%20management%20of%20atrial%20fibrillation%20developed%20in%20collaboration%20with%20the%20European%20Association%20for%20Cardio-Thoracic%20Surgery%20(EACTS):%20The%20Task%20Force%20for%20the%20diagnosis%20and%20management%20of%20atrial%20fibrillation%20of%20the%20European%20Society%20of%20Cardiology%20(ESC)%20Developed%20with%20the%20special%20contribution%20of%20the%20European%20Heart%20Rhythm%20Association%20(EHRA)%20of%20the%20ESC&amp;author=G%20Hindricks&amp;author=T%20Potpara&amp;author=N%20Dagres&amp;author=E%20Arbelo&amp;author=JJ%20Bax&amp;volume=42&amp;issue=5&amp;publication_year=2021&amp;pages=373-498&amp;pmid=32860505&amp;doi=10.1093/eurheartj/ehaa612&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref008">
<span class="label">8.</span><cite>Gorog DA, Gue YX, Chao T-F, Fauchier L, Ferreiro JL, Huber K, et al. Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society. Europace. 2022;24(11):1844–71. doi: 10.1093/europace/euac020

</cite> [<a href="https://doi.org/10.1093/europace/euac020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11636575/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35323922/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Assessment%20and%20mitigation%20of%20bleeding%20risk%20in%20atrial%20fibrillation%20and%20venous%20thromboembolism:%20A%20Position%20Paper%20from%20the%20ESC%20Working%20Group%20on%20Thrombosis,%20in%20collaboration%20with%20the%20European%20Heart%20Rhythm%20Association,%20the%20Association%20for%20Acute%20CardioVascular%20Care%20and%20the%20Asia-Pacific%20Heart%20Rhythm%20Society&amp;author=DA%20Gorog&amp;author=YX%20Gue&amp;author=T-F%20Chao&amp;author=L%20Fauchier&amp;author=JL%20Ferreiro&amp;volume=24&amp;issue=11&amp;publication_year=2022&amp;pages=1844-71&amp;pmid=35323922&amp;doi=10.1093/europace/euac020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref009">
<span class="label">9.</span><cite>Hijazi Z, Oldgren J, Lindbäck J, Alexander JH, Connolly SJ, Eikelboom JW, et al. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016;387(10035):2302–11. doi: 10.1016/S0140-6736(16)00741-8

</cite> [<a href="https://doi.org/10.1016/S0140-6736(16)00741-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27056738/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=The%20novel%20biomarker-based%20ABC%20(age,%20biomarkers,%20clinical%20history)-bleeding%20risk%20score%20for%20patients%20with%20atrial%20fibrillation:%20a%20derivation%20and%20validation%20study&amp;author=Z%20Hijazi&amp;author=J%20Oldgren&amp;author=J%20Lindb%C3%A4ck&amp;author=JH%20Alexander&amp;author=SJ%20Connolly&amp;volume=387&amp;issue=10035&amp;publication_year=2016&amp;pages=2302-11&amp;pmid=27056738&amp;doi=10.1016/S0140-6736(16)00741-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref010">
<span class="label">10.</span><cite>Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, et al. A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. J Am Coll Cardiol. 2011;58(4):395–401. doi: 10.1016/j.jacc.2011.03.031

</cite> [<a href="https://doi.org/10.1016/j.jacc.2011.03.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3175766/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21757117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Coll%20Cardiol&amp;title=A%20new%20risk%20scheme%20to%20predict%20warfarin-associated%20hemorrhage:%20The%20ATRIA%20(Anticoagulation%20and%20Risk%20Factors%20in%20Atrial%20Fibrillation)%20Study&amp;author=MC%20Fang&amp;author=AS%20Go&amp;author=Y%20Chang&amp;author=LH%20Borowsky&amp;author=NK%20Pomernacki&amp;volume=58&amp;issue=4&amp;publication_year=2011&amp;pages=395-401&amp;pmid=21757117&amp;doi=10.1016/j.jacc.2011.03.031&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref011">
<span class="label">11.</span><cite>O’Brien EC, Simon DN, Thomas LE, Hylek EM, Gersh BJ, Ansell JE, et al. The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation. Eur Heart J. 2015;36(46):3258–64. doi: 10.1093/eurheartj/ehv476

</cite> [<a href="https://doi.org/10.1093/eurheartj/ehv476" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4670965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26424865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=The%20ORBIT%20bleeding%20score:%20a%20simple%20bedside%20score%20to%20assess%20bleeding%20risk%20in%20atrial%20fibrillation&amp;author=EC%20O%E2%80%99Brien&amp;author=DN%20Simon&amp;author=LE%20Thomas&amp;author=EM%20Hylek&amp;author=BJ%20Gersh&amp;volume=36&amp;issue=46&amp;publication_year=2015&amp;pages=3258-64&amp;pmid=26424865&amp;doi=10.1093/eurheartj/ehv476&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref012">
<span class="label">12.</span><cite>Fox KAA, Lucas JE, Pieper KS, Bassand J-P, Camm AJ, Fitzmaurice DA, et al. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ Open. 2017;7(12):e017157. doi: 10.1136/bmjopen-2017-017157

</cite> [<a href="https://doi.org/10.1136/bmjopen-2017-017157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5778339/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29273652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMJ%20Open&amp;title=Improved%20risk%20stratification%20of%20patients%20with%20atrial%20fibrillation:%20an%20integrated%20GARFIELD-AF%20tool%20for%20the%20prediction%20of%20mortality,%20stroke%20and%20bleed%20in%20patients%20with%20and%20without%20anticoagulation&amp;author=KAA%20Fox&amp;author=JE%20Lucas&amp;author=KS%20Pieper&amp;author=J-P%20Bassand&amp;author=AJ%20Camm&amp;volume=7&amp;issue=12&amp;publication_year=2017&amp;pmid=29273652&amp;doi=10.1136/bmjopen-2017-017157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref013">
<span class="label">13.</span><cite>Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns HJGM, et al. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024;45(36):3314–414. doi: 10.1093/eurheartj/ehae176

</cite> [<a href="https://doi.org/10.1093/eurheartj/ehae176" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39210723/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=2024%20ESC%20Guidelines%20for%20the%20management%20of%20atrial%20fibrillation%20developed%20in%20collaboration%20with%20the%20European%20Association%20for%20Cardio-Thoracic%20Surgery%20(EACTS)&amp;author=IC%20Van%20Gelder&amp;author=M%20Rienstra&amp;author=KV%20Bunting&amp;author=R%20Casado-Arroyo&amp;author=V%20Caso&amp;volume=45&amp;issue=36&amp;publication_year=2024&amp;pages=3314-414&amp;pmid=39210723&amp;doi=10.1093/eurheartj/ehae176&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref014">
<span class="label">14.</span><cite>Berg DD, Ruff CT, Jarolim P, Giugliano RP, Nordio F, Lanz HJ, et al. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48. Circulation. 2019;139(6):760–71. doi: 10.1161/CIRCULATIONAHA.118.038312

</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.118.038312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6363338/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586727/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Performance%20of%20the%20ABC%20Scores%20for%20Assessing%20the%20Risk%20of%20Stroke%20or%20Systemic%20Embolism%20and%20Bleeding%20in%20Patients%20With%20Atrial%20Fibrillation%20in%20ENGAGE%20AF-TIMI%2048&amp;author=DD%20Berg&amp;author=CT%20Ruff&amp;author=P%20Jarolim&amp;author=RP%20Giugliano&amp;author=F%20Nordio&amp;volume=139&amp;issue=6&amp;publication_year=2019&amp;pages=760-71&amp;pmid=30586727&amp;doi=10.1161/CIRCULATIONAHA.118.038312&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref015">
<span class="label">15.</span><cite>Berg DD, Ruff CT, Morrow DA. Biomarkers for Risk Assessment in Atrial Fibrillation. Clin Chem. 2021;67(1):87–95. doi: 10.1093/clinchem/hvaa298

</cite> [<a href="https://doi.org/10.1093/clinchem/hvaa298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33313695/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Biomarkers%20for%20Risk%20Assessment%20in%20Atrial%20Fibrillation&amp;author=DD%20Berg&amp;author=CT%20Ruff&amp;author=DA%20Morrow&amp;volume=67&amp;issue=1&amp;publication_year=2021&amp;pages=87-95&amp;pmid=33313695&amp;doi=10.1093/clinchem/hvaa298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref016">
<span class="label">16.</span><cite>Hijazi Z, Oldgren J, Siegbahn A, Wallentin L. Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation. Clin Chem. 2017;63(1):152–64. doi: 10.1373/clinchem.2016.255182

</cite> [<a href="https://doi.org/10.1373/clinchem.2016.255182" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27811208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Chem&amp;title=Application%20of%20Biomarkers%20for%20Risk%20Stratification%20in%20Patients%20with%20Atrial%20Fibrillation&amp;author=Z%20Hijazi&amp;author=J%20Oldgren&amp;author=A%20Siegbahn&amp;author=L%20Wallentin&amp;volume=63&amp;issue=1&amp;publication_year=2017&amp;pages=152-64&amp;pmid=27811208&amp;doi=10.1373/clinchem.2016.255182&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref017">
<span class="label">17.</span><cite>Yildirim M, Salbach C, Reich C, Milles BR, Biener M, Frey N, et al. Comparison of the clinical chemistry score to other biomarker algorithms for rapid rule-out of acute myocardial infarction and risk stratification in patients with suspected acute coronary syndrome. Int J Cardiol. 2024;400:131815. doi: 10.1016/j.ijcard.2024.131815

</cite> [<a href="https://doi.org/10.1016/j.ijcard.2024.131815" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38278492/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cardiol&amp;title=Comparison%20of%20the%20clinical%20chemistry%20score%20to%20other%20biomarker%20algorithms%20for%20rapid%20rule-out%20of%20acute%20myocardial%20infarction%20and%20risk%20stratification%20in%20patients%20with%20suspected%20acute%20coronary%20syndrome&amp;author=M%20Yildirim&amp;author=C%20Salbach&amp;author=C%20Reich&amp;author=BR%20Milles&amp;author=M%20Biener&amp;volume=400&amp;publication_year=2024&amp;pages=131815&amp;pmid=38278492&amp;doi=10.1016/j.ijcard.2024.131815&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref018">
<span class="label">18.</span><cite>Yildirim M, Reich C, Salbach C, Biener M, Mueller-Hennessen M, Sörensen NA, et al. Identification of patients with suspected NSTE-ACS in the observe zone: evaluating GRACE 1.0 score and a biomarker panel for risk stratification and management optimization. Clin Res Cardiol. 2025;114(6):783–95. doi: 10.1007/s00392-025-02642-3

</cite> [<a href="https://doi.org/10.1007/s00392-025-02642-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12089253/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40227426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Res%20Cardiol&amp;title=Identification%20of%20patients%20with%20suspected%20NSTE-ACS%20in%20the%20observe%20zone:%20evaluating%20GRACE%201.0%20score%20and%20a%20biomarker%20panel%20for%20risk%20stratification%20and%20management%20optimization&amp;author=M%20Yildirim&amp;author=C%20Reich&amp;author=C%20Salbach&amp;author=M%20Biener&amp;author=M%20Mueller-Hennessen&amp;volume=114&amp;issue=6&amp;publication_year=2025&amp;pages=783-95&amp;pmid=40227426&amp;doi=10.1007/s00392-025-02642-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref019">
<span class="label">19.</span><cite>Shin SY, Han S-J, Kim J-S, Im SI, Shim J, Ahn J, et al. Identification of Markers Associated With Development of Stroke in “Clinically Low-Risk” Atrial Fibrillation Patients. J Am Heart Assoc. 2019;8(21):e012697. doi: 10.1161/JAHA.119.012697

</cite> [<a href="https://doi.org/10.1161/JAHA.119.012697" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6898804/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31668140/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Am%20Heart%20Assoc&amp;title=Identification%20of%20Markers%20Associated%20With%20Development%20of%20Stroke%20in%20%E2%80%9CClinically%20Low-Risk%E2%80%9D%20Atrial%20Fibrillation%20Patients&amp;author=SY%20Shin&amp;author=S-J%20Han&amp;author=J-S%20Kim&amp;author=SI%20Im&amp;author=J%20Shim&amp;volume=8&amp;issue=21&amp;publication_year=2019&amp;pmid=31668140&amp;doi=10.1161/JAHA.119.012697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref020">
<span class="label">20.</span><cite>Salbach C, Yildirim M, Hund H, Biener M, Mueller-Hennessen M, Frey N, et al. Design, rationale and initial findings from the Heidelberg Registry of Atrial Fibrillation on 10,222 patients with atrial fibrillation presenting to an emergency department over an 11-year period. Manuscript submitted for publication; 2024.</cite> [<a href="https://doi.org/10.1161/JAHA.123.033396" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11179873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38639359/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?title=Design,%20rationale%20and%20initial%20findings%20from%20the%20Heidelberg%20Registry%20of%20Atrial%20Fibrillation%20on%2010,222%20patients%20with%20atrial%20fibrillation%20presenting%20to%20an%20emergency%20department%20over%20an%2011-year%20period&amp;author=C%20Salbach&amp;author=M%20Yildirim&amp;author=H%20Hund&amp;author=M%20Biener&amp;author=M%20Mueller-Hennessen&amp;publication_year=2024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref021">
<span class="label">21.</span><cite>Lip GYH, Collet JP, Caterina R de, Fauchier L, Lane DA, Larsen TB, et al. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 2017;19(11):1757–8. doi: 10.1093/europace/eux240

</cite> [<a href="https://doi.org/10.1093/europace/eux240" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29096024/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Antithrombotic%20therapy%20in%20atrial%20fibrillation%20associated%20with%20valvular%20heart%20disease:%20a%20joint%20consensus%20document%20from%20the%20European%20Heart%20Rhythm%20Association%20(EHRA)%20and%20European%20Society%20of%20Cardiology%20Working%20Group%20on%20Thrombosis,%20endorsed%20by%20the%20ESC%20Working%20Group%20on%20Valvular%20Heart%20Disease,%20Cardiac%20Arrhythmia%20Society%20of%20Southern%20Africa%20(CASSA),%20Heart%20Rhythm%20Society%20(HRS),%20Asia%20Pacific%20Heart%20Rhythm%20Society%20(APHRS),%20South%20African%20Heart%20(SA%20Heart)%20Association%20and%20Sociedad%20Latinoamericana%20de%20Estimulaci%C3%B3n%20Card%C3%ADaca%20y%20Electrofisiolog%C3%ADa%20(SOLEACE)&amp;author=GYH%20Lip&amp;author=JP%20Collet&amp;author=de%20Caterina%20R&amp;author=L%20Fauchier&amp;author=DA%20Lane&amp;volume=19&amp;issue=11&amp;publication_year=2017&amp;pages=1757-8&amp;pmid=29096024&amp;doi=10.1093/europace/eux240&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref022">
<span class="label">22.</span><cite>Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–72. doi: 10.1378/chest.09-1584

</cite> [<a href="https://doi.org/10.1378/chest.09-1584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19762550/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chest&amp;title=Refining%20clinical%20risk%20stratification%20for%20predicting%20stroke%20and%20thromboembolism%20in%20atrial%20fibrillation%20using%20a%20novel%20risk%20factor-based%20approach:%20the%20euro%20heart%20survey%20on%20atrial%20fibrillation&amp;author=GYH%20Lip&amp;author=R%20Nieuwlaat&amp;author=R%20Pisters&amp;author=DA%20Lane&amp;author=HJGM%20Crijns&amp;volume=137&amp;issue=2&amp;publication_year=2010&amp;pages=263-72&amp;pmid=19762550&amp;doi=10.1378/chest.09-1584&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref023">
<span class="label">23.</span><cite>Grambsch PM, Therneau TM, Fleming TR. Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics. 1995;51(4):1469–82. 
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8589234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biometrics&amp;title=Diagnostic%20plots%20to%20reveal%20functional%20form%20for%20covariates%20in%20multiplicative%20intensity%20models&amp;author=PM%20Grambsch&amp;author=TM%20Therneau&amp;author=TR%20Fleming&amp;volume=51&amp;issue=4&amp;publication_year=1995&amp;pages=1469-82&amp;pmid=8589234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref024">
<span class="label">24.</span><cite>Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36. doi: 10.1148/radiology.143.1.7063747

</cite> [<a href="https://doi.org/10.1148/radiology.143.1.7063747" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7063747/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=The%20meaning%20and%20use%20of%20the%20area%20under%20a%20receiver%20operating%20characteristic%20(ROC)%20curve&amp;author=JA%20Hanley&amp;author=BJ%20McNeil&amp;volume=143&amp;issue=1&amp;publication_year=1982&amp;pages=29-36&amp;pmid=7063747&amp;doi=10.1148/radiology.143.1.7063747&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref025">
<span class="label">25.</span><cite>Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839–43. doi: 10.1148/radiology.148.3.6878708

</cite> [<a href="https://doi.org/10.1148/radiology.148.3.6878708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/6878708/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=A%20method%20of%20comparing%20the%20areas%20under%20receiver%20operating%20characteristic%20curves%20derived%20from%20the%20same%20cases&amp;author=JA%20Hanley&amp;author=BJ%20McNeil&amp;volume=148&amp;issue=3&amp;publication_year=1983&amp;pages=839-43&amp;pmid=6878708&amp;doi=10.1148/radiology.148.3.6878708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref026">
<span class="label">26.</span><cite>Pencina MJ, D’Agostino RB Sr, D’Agostino RB, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–72; discussion 207-12. doi: 10.1002/sim.2929

</cite> [<a href="https://doi.org/10.1002/sim.2929" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17569110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Stat%20Med&amp;title=Evaluating%20the%20added%20predictive%20ability%20of%20a%20new%20marker:%20from%20area%20under%20the%20ROC%20curve%20to%20reclassification%20and%20beyond&amp;author=MJ%20Pencina&amp;author=RB%20D%E2%80%99Agostino&amp;author=RB%20D%E2%80%99Agostino&amp;author=RS%20Vasan&amp;volume=27&amp;issue=2&amp;publication_year=2008&amp;pages=157-72&amp;pmid=17569110&amp;doi=10.1002/sim.2929&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref027">
<span class="label">27.</span><cite>Chen J-Y, Zhang A-D, Lu H-Y, Guo J, Wang F-F, Li Z-C. CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis. J Geriatr Cardiol. 2013;10(3):258–66. doi: 10.3969/j.issn.1671-5411.2013.03.004

</cite> [<a href="https://doi.org/10.3969/j.issn.1671-5411.2013.03.004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3796700/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24133514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Geriatr%20Cardiol&amp;title=CHADS2%20versus%20CHA2DS2-VASc%20score%20in%20assessing%20the%20stroke%20and%20thromboembolism%20risk%20stratification%20in%20patients%20with%20atrial%20fibrillation:%20a%20systematic%20review%20and%20meta-analysis&amp;author=J-Y%20Chen&amp;author=A-D%20Zhang&amp;author=H-Y%20Lu&amp;author=J%20Guo&amp;author=F-F%20Wang&amp;volume=10&amp;issue=3&amp;publication_year=2013&amp;pages=258-66&amp;pmid=24133514&amp;doi=10.3969/j.issn.1671-5411.2013.03.004&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref028">
<span class="label">28.</span><cite>Hioki H, Miura T, Miyashita Y, Motoki H, Shimada K, Kobayashi M, et al. Risk stratification using the CHA2DS2-VASc score in patients with coronary heart disease undergoing percutaneous coronary intervention; sub-analysis of SHINANO registry. Int J Cardiol Heart Vasc. 2015;7:76–81. doi: 10.1016/j.ijcha.2015.02.007

</cite> [<a href="https://doi.org/10.1016/j.ijcha.2015.02.007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5497243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28785649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int%20J%20Cardiol%20Heart%20Vasc&amp;title=Risk%20stratification%20using%20the%20CHA2DS2-VASc%20score%20in%20patients%20with%20coronary%20heart%20disease%20undergoing%20percutaneous%20coronary%20intervention;%20sub-analysis%20of%20SHINANO%20registry&amp;author=H%20Hioki&amp;author=T%20Miura&amp;author=Y%20Miyashita&amp;author=H%20Motoki&amp;author=K%20Shimada&amp;volume=7&amp;publication_year=2015&amp;pages=76-81&amp;pmid=28785649&amp;doi=10.1016/j.ijcha.2015.02.007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref029">
<span class="label">29.</span><cite>Sen J, Tonkin A, Varigos J, Fonguh S, Berkowitz SD, Yusuf S, et al. CHA2DS2-VASc and CHADS2 scores for risk stratification of major adverse cardiovascular events in the COMPASS trial. European Heart Journal. 2020;41(Supplement_2). doi: 10.1093/ehjci/ehaa946.2906</cite> [<a href="https://doi.org/10.1093/ehjci/ehaa946.2906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Heart%20Journal&amp;title=CHA2DS2-VASc%20and%20CHADS2%20scores%20for%20risk%20stratification%20of%20major%20adverse%20cardiovascular%20events%20in%20the%20COMPASS%20trial&amp;author=J%20Sen&amp;author=A%20Tonkin&amp;author=J%20Varigos&amp;author=S%20Fonguh&amp;author=SD%20Berkowitz&amp;volume=41&amp;publication_year=2020&amp;doi=10.1093/ehjci/ehaa946.2906&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref030">
<span class="label">30.</span><cite>Lee J-K, Hung C-S, Huang C-C, Chen Y-H, Chuang P-Y, Yu J-Y, et al. Use of the CHA2DS2-VASc Score for Risk Stratification of Hospital Admissions Among Patients With Cardiovascular Diseases Receiving a Fourth-Generation Synchronous Telehealth Program: Retrospective Cohort Study. J Med Internet Res. 2019;21(1):e12790. doi: 10.2196/12790

</cite> [<a href="https://doi.org/10.2196/12790" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6374726/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30702437/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Med%20Internet%20Res&amp;title=Use%20of%20the%20CHA2DS2-VASc%20Score%20for%20Risk%20Stratification%20of%20Hospital%20Admissions%20Among%20Patients%20With%20Cardiovascular%20Diseases%20Receiving%20a%20Fourth-Generation%20Synchronous%20Telehealth%20Program:%20Retrospective%20Cohort%20Study&amp;author=J-K%20Lee&amp;author=C-S%20Hung&amp;author=C-C%20Huang&amp;author=Y-H%20Chen&amp;author=P-Y%20Chuang&amp;volume=21&amp;issue=1&amp;publication_year=2019&amp;pmid=30702437&amp;doi=10.2196/12790&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref031">
<span class="label">31.</span><cite>Wang B-Y, Lin F-Y, Ku M-S, Wang Y-H, Lee K-Y, Ho S-W. CHA2DS2-VASc Score for Major Adverse Cardiovascular Events Stratification in Patients with Pneumonia with and without Atrial Fibrillation. J Clin Med. 2021;10(18):4093. doi: 10.3390/jcm10184093

</cite> [<a href="https://doi.org/10.3390/jcm10184093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8466520/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34575202/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Med&amp;title=CHA2DS2-VASc%20Score%20for%20Major%20Adverse%20Cardiovascular%20Events%20Stratification%20in%20Patients%20with%20Pneumonia%20with%20and%20without%20Atrial%20Fibrillation&amp;author=B-Y%20Wang&amp;author=F-Y%20Lin&amp;author=M-S%20Ku&amp;author=Y-H%20Wang&amp;author=K-Y%20Lee&amp;volume=10&amp;issue=18&amp;publication_year=2021&amp;pages=4093&amp;pmid=34575202&amp;doi=10.3390/jcm10184093&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref032">
<span class="label">32.</span><cite>Cheng Y-T, Chang F-L, Li P-H, Lu W-C, Chiu C-S. Assessing the Suitability of CHA2DS2-VASc for Predicting Adverse Limb Events and Cardiovascular Outcomes in Peripheral Artery Disease Patients with Percutaneous Transluminal Angioplasty: A Retrospective Cohort Study. Biomedicines. 2024;12(6):1374. doi: 10.3390/biomedicines12061374

</cite> [<a href="https://doi.org/10.3390/biomedicines12061374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11202305/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38927581/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicines&amp;title=Assessing%20the%20Suitability%20of%20CHA2DS2-VASc%20for%20Predicting%20Adverse%20Limb%20Events%20and%20Cardiovascular%20Outcomes%20in%20Peripheral%20Artery%20Disease%20Patients%20with%20Percutaneous%20Transluminal%20Angioplasty:%20A%20Retrospective%20Cohort%20Study&amp;author=Y-T%20Cheng&amp;author=F-L%20Chang&amp;author=P-H%20Li&amp;author=W-C%20Lu&amp;author=C-S%20Chiu&amp;volume=12&amp;issue=6&amp;publication_year=2024&amp;pages=1374&amp;pmid=38927581&amp;doi=10.3390/biomedicines12061374&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref033">
<span class="label">33.</span><cite>Champsi A, Mobley AR, Subramanian A, Nirantharakumar K, Wang X, Shukla D, et al. Gender and contemporary risk of adverse events in atrial fibrillation. Eur Heart J. 2024;45(36):3707–17. doi: 10.1093/eurheartj/ehae539

</cite> [<a href="https://doi.org/10.1093/eurheartj/ehae539" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11439109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39217497/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Gender%20and%20contemporary%20risk%20of%20adverse%20events%20in%20atrial%20fibrillation&amp;author=A%20Champsi&amp;author=AR%20Mobley&amp;author=A%20Subramanian&amp;author=K%20Nirantharakumar&amp;author=X%20Wang&amp;volume=45&amp;issue=36&amp;publication_year=2024&amp;pages=3707-17&amp;pmid=39217497&amp;doi=10.1093/eurheartj/ehae539&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref034">
<span class="label">34.</span><cite>Yoshimura H, Providencia R, Finan C, Schmidt AF, Lip GYH. Refining the CHA2DS2VASc risk stratification scheme: shall we drop the sex category criterion?. Europace. 2024;26(11):euae280. doi: 10.1093/europace/euae280

</cite> [<a href="https://doi.org/10.1093/europace/euae280" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11574618/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39522169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Refining%20the%20CHA2DS2VASc%20risk%20stratification%20scheme:%20shall%20we%20drop%20the%20sex%20category%20criterion?&amp;author=H%20Yoshimura&amp;author=R%20Providencia&amp;author=C%20Finan&amp;author=AF%20Schmidt&amp;author=GYH%20Lip&amp;volume=26&amp;issue=11&amp;publication_year=2024&amp;pmid=39522169&amp;doi=10.1093/europace/euae280&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref035">
<span class="label">35.</span><cite>Lip GYH, Proietti M, Potpara T, Mansour M, Savelieva I, Tse HF, et al. Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal. Europace. 2023;25(9):euad226. doi: 10.1093/europace/euad226

</cite> [<a href="https://doi.org/10.1093/europace/euad226" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10451006/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37622590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Europace&amp;title=Atrial%20fibrillation%20and%20stroke%20prevention:%2025%20years%20of%20research%20at%20EP%20Europace%20journal&amp;author=GYH%20Lip&amp;author=M%20Proietti&amp;author=T%20Potpara&amp;author=M%20Mansour&amp;author=I%20Savelieva&amp;volume=25&amp;issue=9&amp;publication_year=2023&amp;pmid=37622590&amp;doi=10.1093/europace/euad226&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref036">
<span class="label">36.</span><cite>Yeh RW, Secemsky EA, Kereiakes DJ, Normand S-LT, Gershlick AH, Cohen DJ, et al. Development and Validation of a Prediction Rule for Benefit and Harm of Dual Antiplatelet Therapy Beyond 1 Year After Percutaneous Coronary Intervention. JAMA. 2016;315(16):1735–49. doi: 10.1001/jama.2016.3775

</cite> [<a href="https://doi.org/10.1001/jama.2016.3775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5408574/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27022822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Development%20and%20Validation%20of%20a%20Prediction%20Rule%20for%20Benefit%20and%20Harm%20of%20Dual%20Antiplatelet%20Therapy%20Beyond%201%20Year%20After%20Percutaneous%20Coronary%20Intervention&amp;author=RW%20Yeh&amp;author=EA%20Secemsky&amp;author=DJ%20Kereiakes&amp;author=S-LT%20Normand&amp;author=AH%20Gershlick&amp;volume=315&amp;issue=16&amp;publication_year=2016&amp;pages=1735-49&amp;pmid=27022822&amp;doi=10.1001/jama.2016.3775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref037">
<span class="label">37.</span><cite>Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, et al. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017;389(10073):1025–34. doi: 10.1016/S0140-6736(17)30397-5

</cite> [<a href="https://doi.org/10.1016/S0140-6736(17)30397-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28290994/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Derivation%20and%20validation%20of%20the%20predicting%20bleeding%20complications%20in%20patients%20undergoing%20stent%20implantation%20and%20subsequent%20dual%20antiplatelet%20therapy%20(PRECISE-DAPT)%20score:%20a%20pooled%20analysis%20of%20individual-patient%20datasets%20from%20clinical%20trials&amp;author=F%20Costa&amp;author=D%20van%20Klaveren&amp;author=S%20James&amp;author=D%20Heg&amp;author=L%20R%C3%A4ber&amp;volume=389&amp;issue=10073&amp;publication_year=2017&amp;pages=1025-34&amp;pmid=28290994&amp;doi=10.1016/S0140-6736(17)30397-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref038">
<span class="label">38.</span><cite>Ueki Y, Bär S, Losdat S, Otsuka T, Zanchin C, Zanchin T, et al. Validation of the Academic Research Consortium for High Bleeding Risk (ARC-HBR) criteria in patients undergoing percutaneous coronary intervention and comparison with contemporary bleeding risk scores. EuroIntervention. 2020;16(5):371–9. doi: 10.4244/EIJ-D-20-00052

</cite> [<a href="https://doi.org/10.4244/EIJ-D-20-00052" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32065586/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EuroIntervention&amp;title=Validation%20of%20the%20Academic%20Research%20Consortium%20for%20High%20Bleeding%20Risk%20(ARC-HBR)%20criteria%20in%20patients%20undergoing%20percutaneous%20coronary%20intervention%20and%20comparison%20with%20contemporary%20bleeding%20risk%20scores&amp;author=Y%20Ueki&amp;author=S%20B%C3%A4r&amp;author=S%20Losdat&amp;author=T%20Otsuka&amp;author=C%20Zanchin&amp;volume=16&amp;issue=5&amp;publication_year=2020&amp;pages=371-9&amp;pmid=32065586&amp;doi=10.4244/EIJ-D-20-00052&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref039">
<span class="label">39.</span><cite>Brabrand M, Lassen AT, Knudsen T, Hallas J. Seven-day mortality can be predicted in medical patients by blood pressure, age, respiratory rate, loss of independence, and peripheral oxygen saturation (the PARIS score): a prospective cohort study with external validation. PLoS One. 2015;10(4):e0122480. doi: 10.1371/journal.pone.0122480

</cite> [<a href="https://doi.org/10.1371/journal.pone.0122480" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4395094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25867881/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Seven-day%20mortality%20can%20be%20predicted%20in%20medical%20patients%20by%20blood%20pressure,%20age,%20respiratory%20rate,%20loss%20of%20independence,%20and%20peripheral%20oxygen%20saturation%20(the%20PARIS%20score):%20a%20prospective%20cohort%20study%20with%20external%20validation&amp;author=M%20Brabrand&amp;author=AT%20Lassen&amp;author=T%20Knudsen&amp;author=J%20Hallas&amp;volume=10&amp;issue=4&amp;publication_year=2015&amp;pmid=25867881&amp;doi=10.1371/journal.pone.0122480&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref040">
<span class="label">40.</span><cite>Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, et al. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation. 2012;125(13):1605–16. doi: 10.1161/CIRCULATIONAHA.111.038729

</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.111.038729" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22374183/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Cardiac%20biomarkers%20are%20associated%20with%20an%20increased%20risk%20of%20stroke%20and%20death%20in%20patients%20with%20atrial%20fibrillation:%20a%20Randomized%20Evaluation%20of%20Long-term%20Anticoagulation%20Therapy%20(RE-LY)%20substudy&amp;author=Z%20Hijazi&amp;author=J%20Oldgren&amp;author=U%20Andersson&amp;author=SJ%20Connolly&amp;author=MD%20Ezekowitz&amp;volume=125&amp;issue=13&amp;publication_year=2012&amp;pages=1605-16&amp;pmid=22374183&amp;doi=10.1161/CIRCULATIONAHA.111.038729&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="pone.0330164.ref041">
<span class="label">41.</span><cite>Providência R, Paiva L, Barra S. Risk stratification of patients with atrial fibrillation: Biomarkers and other future perspectives. World J Cardiol. 2012;4(6):195–200. doi: 10.4330/wjc.v4.i6.195

</cite> [<a href="https://doi.org/10.4330/wjc.v4.i6.195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3386309/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22761972/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20J%20Cardiol&amp;title=Risk%20stratification%20of%20patients%20with%20atrial%20fibrillation:%20Biomarkers%20and%20other%20future%20perspectives&amp;author=R%20Provid%C3%AAncia&amp;author=L%20Paiva&amp;author=S%20Barra&amp;volume=4&amp;issue=6&amp;publication_year=2012&amp;pages=195-200&amp;pmid=22761972&amp;doi=10.4330/wjc.v4.i6.195&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p">
<span>S1 Fig. Distribution of CHA<sub>2</sub>DS<sub>2</sub>-VASc score across the entire cohort.</span><p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s001.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s001.tif</a><sup> (247.9KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p">
<span>S2 Fig. Kaplan-Meier analysis for all-cause mortality, stroke, major bleeding and myocardial infarction classified by CHA<sub>2</sub>DS<sub>2</sub>-VASc score risk category.</span><p>Patients with a high-risk category according to CHA<sub>2</sub>DS<sub>2</sub>VASc-score had a higher all-cause mortality (A), a higher probability of ischemic stroke rate (B), a higher probability of major bleeding events (C) and higher risk for myocardial infarction (D). Abbreviatons: MI, myocardial infarction.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s002.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s002.tif</a><sup> (890.3KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p">
<span>S3 Fig. Kaplan-Meier analysis for all-cause mortality, stroke, major bleeding and myocardial infarction classified by hs-cTnT category.</span><p>Patients with a high hs-cTnT had a higher all-cause mortality (A), a higher probability of ischemic stroke (B), a higher probability of major bleeding (C) and higher risk for myocardial infarction (D). Abbreviations: MI, myocardial infarction, hs-cTnT, highly sensitive cardiac troponin T.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s003.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s003.tif</a><sup> (745.6KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p">
<span>S4 Fig. Kaplan Meier analysis for the composite endpoint stratified by hs-cTnT categories for patients in intermediate-risk category according to CHA<sub>2</sub>DS<sub>2</sub>-VA score.</span><p>Abbreviations: EP, endpoint; hs-cTnT, highly sensitive cardiac troponin T.</p>
<p>(TIF)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s004.tif" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s004.tif</a><sup> (421.2KB, tif) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="caption p">
<span>S1 Table. AUC analysis for hs-cTnT in predicting outcome variables. Abbreviations: AUC, area under the curve, CI, confidence interval.</span><p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s005.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s005.docx</a><sup> (12.8KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="caption p">
<span>S2 Table. Outcomes and HR classified by CHA₂DS₂-VA risk category.</span><p>*The composite EP consisted of stroke or major bleeding, p-value was calculated as p-value for trend and log rank test for HRs. Abbreviations: CI, confidence interval; HR, hazard ratio; MI, myocardial infarction.</p>
<p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s006.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s006.docx</a><sup> (14.3KB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="caption p">
<span>S3 Table. AUCs of the CHA<sub>2</sub>DS<sub>2</sub>VA score separated for outcome variables.</span><p>*The composite EP consisted of stroke and major bleeding events. Abbreviations: AUC, area under the curve, CI, confidence interval, EP endpoint.</p>
<p>(DOCX)</p>
</div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12370022/bin/pone.0330164.s007.docx" data-ga-action="click_feat_suppl" class="usa-link">pone.0330164.s007.docx</a><sup> (12.9KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data for this study was retrospectively collected from routine care of consecutive patients admitted to the emergency department. The study was approved by the Ethics Committee of the Medical Faculty of Heidelberg without requiring informed consent. However, patient-level data cannot be shared publicly as informed consent is required for such sharing, which is not feasible in this context. For inquiries regarding the data, the study group of cardiac biomarkers at the Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, can provide assistance. Requests will be handled in accordance with the study protocol and relevant regulations (e.g. the Declaration of Helsinki (2008) and General Data Protection Regulation (EU) 2016/679). Address for correspondence: Study Group Cardiac Biomarkers, Department of Cardiology, Angiology, and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 410, 69120 Heidelberg, Germany; E-mail: <span>Giannitsis.Studienbuero@med.uni-heidelberg.de</span>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from PLOS One are provided here courtesy of <strong>PLOS</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1371/journal.pone.0330164"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/pone.0330164.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12370022/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12370022/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12370022%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12370022/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12370022/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12370022/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40839563/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12370022/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40839563/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12370022/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12370022/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="ZRVU3o5O1R1lv3f9wHlIksgc6hfJXQo10Cnc48u6cXmzHCmWP34XtmZsG5tDdEZZ">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
